{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T03:09:52Z","timestamp":1763867392478,"version":"3.41.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Odontology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10266-025-01057-w","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T18:25:44Z","timestamp":1739557544000},"page":"1137-1147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HNF1A-AS1 promotes oral squamous cell carcinoma progression via regulating miR-138\/CDK6 pathway"],"prefix":"10.1007","volume":"113","author":[{"given":"Bingxin","family":"Mei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinmin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"issue":"1","key":"1057_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","volume":"15","author":"Y Tan","year":"2023","unstructured":"Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S, Nice EC, Tang J, Huang C. Oral squamous cell carcinomas: state of the field and emerging directions. Int J Oral Sci. 2023;15(1):44.","journal-title":"Int J Oral Sci"},{"issue":"4","key":"1057_CR2","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.3390\/curroncol30040283","volume":"30","author":"M Badwelan","year":"2023","unstructured":"Badwelan M, Muaddi H, Ahmed A, Lee KT, Tran SD. Oral Squamous Cell Carcinoma and Concomitant Primary Tumors, What Do We Know? A Review of the Literature. Curr Oncol (Toronto, Ont). 2023;30(4):3721\u201334.","journal-title":"Curr Oncol (Toronto, Ont)"},{"key":"1057_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105451","volume":"121","author":"A Chamoli","year":"2021","unstructured":"Chamoli A, Gosavi AS, Shirwadkar UP, Wangdale KV, Behera SK, Kurrey NK, Kalia K, Mandoli A. Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics. Oral Oncol. 2021;121: 105451.","journal-title":"Oral Oncol"},{"issue":"21","key":"1057_CR4","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.2174\/1381612828666220520113846","volume":"28","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhao F, Tan F, Tang L, Du Z, Mou J, Zhou G, Yuan C. HNF1A-AS1: A Tumor-associated Long Non-coding RNA. Curr Pharm Des. 2022;28(21):1720\u20139.","journal-title":"Curr Pharm Des"},{"key":"1057_CR5","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.2147\/OTT.S231249","volume":"13","author":"X Guo","year":"2020","unstructured":"Guo X, Zhang Y, Liu L, Yang W, Zhang Q. HNF1A-AS1 Regulates Cell Migration, Invasion and Glycolysis via Modulating miR-124\/MYO6 in Colorectal Cancer Cells. Onco Targets Ther. 2020;13:1507\u201318.","journal-title":"Onco Targets Ther"},{"issue":"8","key":"1057_CR6","first-page":"2261","volume":"22","author":"YH Wang","year":"2018","unstructured":"Wang YH, Liu YH, Ji YJ, Wei Q, Gao TB. Upregulation of long non-coding RNA HNF1A-AS1 is associated with poor prognosis in urothelial carcinoma of the bladder. Eur Rev Med Pharmacol Sci. 2018;22(8):2261\u20135.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"1057_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s10565-021-09595-z","volume":"37","author":"Z Wang","year":"2021","unstructured":"Wang Z, Liu L, Du Y, Mi Y, Wang L. The HNF1A-AS1\/miR-92a-3p axis affects the radiosensitivity of non-small cell lung cancer by competitively regulating the JNK pathway. Cell Biol Toxicol. 2021;37(5):715\u201329.","journal-title":"Cell Biol Toxicol"},{"issue":"4","key":"1057_CR8","first-page":"371","volume":"36","author":"P Lou","year":"2021","unstructured":"Lou P, Ding T, Zhan X. Long Noncoding RNA HNF1A-AS1 Regulates Osteosarcoma Advancement Through Modulating the miR-32-5p\/HMGB1 Axis. Cancer Biother Radiopharm. 2021;36(4):371\u201381.","journal-title":"Cancer Biother Radiopharm"},{"issue":"4","key":"1057_CR9","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1080\/15384047.2018.1529119","volume":"20","author":"Z Liu","year":"2019","unstructured":"Liu Z, Li H, Fan S, Lin H, Lian W. STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway. Cancer Biol Ther. 2019;20(4):444\u201353.","journal-title":"Cancer Biol Ther"},{"key":"1057_CR10","doi-asserted-by":"publisher","first-page":"111528","DOI":"10.1016\/j.biopha.2021.111528","volume":"138","author":"BM Hussen","year":"2021","unstructured":"Hussen BM, Hidayat HJ, Salihi A, Sabir DK, Taheri M, Ghafouri-Fard S. MicroRNA: A signature for cancer progression. Biomed & Pharmacother Biomedecine & Pharmacotherapie. 2021;138:111528.","journal-title":"Biomed & Pharmacother Biomedecine & Pharmacotherapie"},{"issue":"14","key":"1057_CR11","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.7150\/ijbs.47203","volume":"16","author":"B He","year":"2020","unstructured":"He B, Zhao Z, Cai Q, Zhang Y, Zhang P, Shi S, Xie H, Peng X, Yin W, Tao Y, et al. miRNA-based biomarkers, therapies, and resistance in Cancer. Int J Biol Sci. 2020;16(14):2628\u201347.","journal-title":"Int J Biol Sci"},{"issue":"10","key":"1057_CR12","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/jop.12933","volume":"48","author":"D Zeng","year":"2019","unstructured":"Zeng D, Xu H, Ji N, Li J, Zhou M, Dan H, Zhou Y, Zeng X, Jiang L, Chen Q. In situ measurement of miR-138 expression in oral squamous cell carcinoma tissue supports the role of this microRNA as a tumor suppressor. J Oral Pathol Med\u202f: Official Publication Int Association Oral Pathologists Am Academy Oral Pathol. 2019;48(10):911\u20138.","journal-title":"J Oral Pathol Med : Official Publication Int Association Oral Pathologists Am Academy Oral Pathol"},{"issue":"3","key":"1057_CR13","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.3892\/etm.2017.4720","volume":"14","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, He Y, Nie M, Cai W. Roles of miR-138 and ISG15 in oral squamous cell carcinoma. Exp Ther Med. 2017;14(3):2329\u201334.","journal-title":"Exp Ther Med"},{"issue":"6","key":"1057_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41568-022-00456-3","volume":"22","author":"S Goel","year":"2022","unstructured":"Goel S, Bergholz JS, Zhao JJ. Targeting CDK4 and CDK6 in cancer. Nat Rev Cancer. 2022;22(6):356\u201372.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"1057_CR15","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ccell.2021.03.010","volume":"39","author":"JM Suski","year":"2021","unstructured":"Suski JM, Braun M, Strmiska V, Sicinski P. Targeting cell-cycle machinery in cancer. Cancer Cell. 2021;39(6):759\u201378.","journal-title":"Cancer Cell"},{"issue":"11","key":"1057_CR16","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1002\/ijc.33054","volume":"147","author":"S Nebenfuehr","year":"2020","unstructured":"Nebenfuehr S, Kollmann K, Sexl V. The role of CDK6 in cancer. Int J Cancer. 2020;147(11):2988\u201395.","journal-title":"Int J Cancer"},{"key":"1057_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semcancer.2020.12.012","volume":"75","author":"EM McCabe","year":"2021","unstructured":"McCabe EM, Rasmussen TP. lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions. Semin Cancer Biol. 2021;75:38\u201348.","journal-title":"Semin Cancer Biol"},{"issue":"23","key":"1057_CR18","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.3390\/cancers13235944","volume":"13","author":"J Tang","year":"2021","unstructured":"Tang J, Fang X, Chen J, Zhang H, Tang Z. Long Non-Coding RNA (lncRNA) in Oral Squamous Cell Carcinoma: Biological Function and Clinical Application. Cancers. 2021;13(23):5944.","journal-title":"Cancers"},{"issue":"2","key":"1057_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.23736\/S2724-5985.21.02993-4","volume":"68","author":"C Gao","year":"2022","unstructured":"Gao C, Guo C, Liu K, Guo N. LncRNA HOTAIR promotes proliferation and migration of OSCC cells via targeting miR-126. Minerva Gastroenterol. 2022;68(2):245\u20137.","journal-title":"Minerva Gastroenterol"},{"issue":"8","key":"1057_CR20","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41419-022-05157-1","volume":"13","author":"W Zhu","year":"2022","unstructured":"Zhu W, Wang J, Liu X, Xu Y, Zhai R, Zhang J, Wang M, Wang M, Liu L. lncRNA CYTOR promotes aberrant glycolysis and mitochondrial respiration via HNRNPC-mediated ZEB1 stabilization in oral squamous cell carcinoma. Cell Death Dis. 2022;13(8):703.","journal-title":"Cell Death Dis"},{"key":"1057_CR21","doi-asserted-by":"publisher","first-page":"109623","DOI":"10.1016\/j.biopha.2019.109623","volume":"121","author":"X Niu","year":"2020","unstructured":"Niu X, Yang B, Liu F, Fang Q. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98\u20135p to upregulate YBX2 expression. Biomed Pharmacother Biomedecine & Pharmacotherapie. 2020;121:109623.","journal-title":"Biomed Pharmacother Biomedecine & Pharmacotherapie"},{"issue":"25","key":"1057_CR22","doi-asserted-by":"publisher","first-page":"e2207549","DOI":"10.1002\/advs.202207549","volume":"10","author":"W Zhou","year":"2023","unstructured":"Zhou W, Feng Y, Lin C, Chao CK, He Z, Zhao S, Xue J, Zhao XY, Cao W. Yin Yang 1-Induced Long Noncoding RNA DUXAP9 Drives the Progression of Oral Squamous Cell Carcinoma by Blocking CDK1-Mediated EZH2 Degradation. Adv Sci. 2023;10(25):e2207549.","journal-title":"Adv Sci"},{"issue":"4","key":"1057_CR23","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/bab.2233","volume":"69","author":"M Asadi","year":"2022","unstructured":"Asadi M, Taghizadeh S, Kaviani E, Vakili O, Taheri-Anganeh M, Tahamtan M, Savardashtaki A. Caspase-3: Structure, function, and biotechnological aspects. Biotechnol Appl Biochem. 2022;69(4):1633\u201345.","journal-title":"Biotechnol Appl Biochem"},{"issue":"3","key":"1057_CR24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146(3):353\u20138.","journal-title":"Cell"},{"issue":"5","key":"1057_CR25","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/cpt.355","volume":"99","author":"MD Ballantyne","year":"2016","unstructured":"Ballantyne MD, McDonald RA, Baker AH. lncRNA\/MicroRNA interactions in the vasculature. Clin Pharmacol Ther. 2016;99(5):494\u2013501.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"1057_CR26","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12885-022-09477-5","volume":"22","author":"R Chen","year":"2022","unstructured":"Chen R, Gan Q, Zhao S, Zhang D, Wang S, Yao L, Yuan M, Cheng J. DNA methylation of miR-138 regulates cell proliferation and EMT in cervical cancer by targeting EZH2. BMC Cancer. 2022;22(1):488.","journal-title":"BMC Cancer"},{"key":"1057_CR27","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.2147\/OTT.S242929","volume":"13","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang D, Li Y, Fang F. MiR-138 Suppresses the PDK1 Expression to Decrease the Oxaliplatin Resistance of Colorectal Cancer. Onco Targets Ther. 2020;13:3607\u201318.","journal-title":"Onco Targets Ther"},{"key":"1057_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.oraloncology.2017.07.026","volume":"73","author":"S Li","year":"2017","unstructured":"Li S, Chen X, Liu X, Yu Y, Pan H, Haak R, Schmidt J, Ziebolz D, Schmalz G. Complex integrated analysis of lncRNAs-miRNAs-mRNAs in oral squamous cell carcinoma. Oral Oncol. 2017;73:1\u20139.","journal-title":"Oral Oncol"},{"key":"1057_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2022.105363","volume":"136","author":"Y Tai","year":"2022","unstructured":"Tai Y, Li Y, Zhang M. Silencing of circ_OSBPL10 affects the functional behaviors of oral squamous cell carcinoma cells by the miR-299-3p\/CDK6 axis. Arch Oral Biol. 2022;136: 105363.","journal-title":"Arch Oral Biol"},{"key":"1057_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2019.105663","volume":"119","author":"X Wang","year":"2020","unstructured":"Wang X, Chang K, Gao J, Wei J, Xu G, Xiao L, Song G. MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6. Int J Biochem Cell Biol. 2020;119: 105663.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"1057_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","volume":"6","author":"L Zhong","year":"2021","unstructured":"Zhong L, Li Y, Xiong L, Wang W, Wu M, Yuan T, Yang W, Tian C, Miao Z, Wang T, et al. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal Transduct Target Ther. 2021;6(1):201.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"1057_CR32","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1038\/s12276-022-00864-3","volume":"54","author":"HY Min","year":"2022","unstructured":"Min HY, Lee HY. Molecular targeted therapy for anticancer treatment. Exp Mol Med. 2022;54(10):1670\u201394.","journal-title":"Exp Mol Med"}],"container-title":["Odontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10266-025-01057-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10266-025-01057-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10266-025-01057-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T19:40:22Z","timestamp":1750362022000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10266-025-01057-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1057"],"URL":"https:\/\/doi.org\/10.1007\/s10266-025-01057-w","relation":{},"ISSN":["1618-1247","1618-1255"],"issn-type":[{"type":"print","value":"1618-1247"},{"type":"electronic","value":"1618-1255"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"29 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study was approved by the ethical review committee of the The First Affiliated Hospital of Gannan Medical University. Written informed consent was obtained from all enrolled patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}}]}}